Home Tools
Log in
Cart

Search Result

Search Results for " trap "

20

Compounds

Cat No. Product Name Synonyms Targets
T7625 TRAP-6 PAR-1 agonist peptide,Thrombin Receptor Activator Peptide 6,TRAP-6(2TFA) Protease-activated Receptor
TRAP-6 (Thrombin Receptor Activator Peptide 6)(2TFA) is an agonist of protease-activated receptor 1 (PAR1).
T38852L TRAP-6 amide acetate Protease-activated Receptor
TRAP-6 amide acetate is a PAR-1 thrombin receptor agonist peptide[1].
T23475 Trap-101 hydrochloride Trap 101 Others
nociceptin/orphanin FQ (NOP) receptor antagonist
T38852 TRAP-6 amide
TRAP-6 amide is a PAR-1 thrombin receptor agonist peptide.
T38743 Scrambled TRAP Fragment
Scrambled TRAP Fragment is a variant of the TRAP Fragment compound, characterized by its random amino acid sequence. It is typically employed as a negative control due to its similarity in composition to the active fragm...
T38887 TRAP-6 amide TFA
TRAP-6 amide TFA is a PAR-1 thrombin receptor agonist peptide.
T78099 Iso-TRAP-6 iso-SFLLRN
Iso-TRAP-6 (iso-SFLLRN) is an analog of TRAP-6 and a PAR-1 agonist, utilizing isoserine in place of serine as the first amino acid, and is capable of activating platelets [1].
T35867 TRAP-6 Peptide (trifluoroacetate salt)
TRAP-6 peptide is a hexapeptide corresponding to residues 42-47 of protease-activated receptor 1 (PAR1). It acts as an agonist of PAR1, inducing platelet aggregation in human platelet-rich plasma ex vivo (EC50 = 0.8 μM)....
T80111 TRAP-5 amide
TRAP-5 amide is a peptide agonist for protease-activated receptor 1 (PAR 1) [1].
T7496 Thrombin Receptor Activator for Peptide 5 (TRAP-5) Thrombin Receptor Activator for Peptide Protease-activated Receptor
Thrombin Receptor Activator for Peptide 5 (TRAP-5), also known as Coagulation Factor II Receptor (1-5) or Proteinase Activated Receptor 1 (1-5), is employed in coronary heart disease (CHD) research.
T60557 TRAP-6-IN-1
TRAP-6-IN-1 (Compound 8) is a dual inhibitor of collagen and TRAP-6 with IC 50 values of 17.12 μM and 11.88 μM, respectively. TRAP-6-IN-1 non-competitively inhibits agonist-induced platelet aggregation[1].
T78545 FLLRN TRAP-6 (2-6)
FLLRN is a biologically active peptide serving as a PAR1-specific antagonist.
TN1722 Hamamelitannin Antifection
Hamamelitannin has cytotoxic, and antibiofilm activities. It increases the susceptibility of S. aureus to antibiotic treatment in in vivo Caenorhabditis elegans and mouse mammary gland infection models. It also has a hig...
T8958 PU-H54 GPR
PU-H54 is a purine-based inhibitor of Grp94. It is a Grp94-selective resorcinol-based inhibitor isolated through probing of the exclusive binding region of S2 subpocket in Grp94.
TP1015 NFAT Inhibitor VIVIT peptide Others
NFAT Inhibitor (VIVIT peptide) is a cell-permeable compound that selectively inhibits calcineurin-mediated dephosphorylation of NFAT.
T20494L Acetyl tetrapeptide-15 Acetate Skinasensyl Acetate,Acetyl tetrapeptide-15 Acetate (928007-64-1 Free base)
Acetyl tetrapeptide-15 Acetate (Skinasensyl Acetate), a synthetic peptide used in cosmetic products for sensitive skin, is an endomorphin-2 derivative that extends the range of neuronal excitability thresholds in the μ-o...
TP2364L Acetyl tetrapeptide-3 Acetate Acetyl tetrapeptide-3 Acetate(827306-88-7 Free base) Others
Acetyl tetrapeptide-3 Acetate is a biomimetic peptide.
TP2498 Tetrapeptide-30 Acetate Tetrapeptide-30 Acetate(1036207-61-0 Free base) Others
Tetrapeptide-30 Acetate (Tetrapeptide-30 Acetate) is a synthetic peptide containing the amino acids proline, glutamic acid, and lysine. It acts on and within specific targets of skin to reduce factors and interrupt the p...
TP2497 Myristoyl Tetrapeptide-12 Acetate Myristoyl Tetrapeptide-12 Acetate(959610-24-3 Free base) Others
Myristoyl Tetrapeptide-12 Acetate (Myristoyl Tetrapeptide-12 Acetate (959610-24-3 Free base)) , the reaction product of myristic acid and Tetrapeptide-12, is a peptide stimulating hair and eyelash growth and enhancing th...
T7221 Satraplatin BMS182751,JM216,BMY45594 DNA Alkylator/Crosslinker , DNA Alkylation
Satraplatin (BMS182751) is an orally available antineoplastic platinum(IV) complex.Satraplatin has a favorable toxicity profile and appears to have clinical activity against a variety of malignancies.
1 2 3 4 5 6
TargetMol